His main research concerns Allergen, Allergy, Immunology, Immunoglobulin E and Placebo. His Allergen study incorporates themes from Nasal Lavage Fluid and Pollen. His research on Allergy focuses in particular on House dust mite.
His study connects Cystic fibrosis and Immunology. As part of one scientific family, Friedrich Horak deals mainly with the area of Immunoglobulin E, narrowing it down to issues related to the Mite, and often Antigen and Sensitization. His Placebo research integrates issues from Anesthesia, Internal medicine and Nasal congestion.
Friedrich Horak focuses on Immunology, Allergy, Allergen, Placebo and Anesthesia. His Allergy study deals with Provocation test intersecting with Dimethindene and Nasal Lavage Fluid. His study in Allergen is interdisciplinary in nature, drawing from both Molecular biology, Pollen, Antigen and Mite.
His research in Placebo intersects with topics in Internal medicine, Adverse effect, Randomized controlled trial, Clinical endpoint and Environmental exposure. Friedrich Horak has included themes like Gastroenterology, Placebo-controlled study, House dust mite and Loratadine in his Internal medicine study. His Anesthesia research is multidisciplinary, incorporating elements of Crossover study, Nasal congestion and Nasal administration.
Friedrich Horak mostly deals with Immunology, House dust mite, Placebo, Sublingual immunotherapy and Allergen. His is involved in several facets of Immunology study, as is seen by his studies on Cytokine, Allergy, Sensitization, Immunotherapy and Allergen immunotherapy. His Allergy research includes elements of Nasal spray, Provocation test and Mucous membrane of nose.
His Placebo research is multidisciplinary, incorporating perspectives in Internal medicine and Clinical endpoint. His Clinical endpoint study combines topics in areas such as Anesthesia and Nasal administration. The study incorporates disciplines such as Antigen and Mite in addition to Allergen.
Friedrich Horak mainly investigates Immunology, Placebo, Clinical endpoint, Allergy and Immunotherapy. Friedrich Horak has researched Immunology in several fields, including Quality of life and Risk factor. His Clinical endpoint research incorporates elements of Anesthesia, Asthma, Environmental exposure and Nasal administration.
The Allergy study which covers Internal medicine that intersects with Pollen. His study looks at the relationship between Immunotherapy and topics such as Antigen-presenting cell, which overlap with Allergen immunotherapy. The research on Allergen and Immunoglobulin E is part of his House dust mite project.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Alain Didier;Hans-Jörgen Malling;Margitta Worm;Friedrich Horak.
The Journal of Allergy and Clinical Immunology (2007)
Vaccination with genetically engineered allergens prevents progression of allergic disease
V. Niederberger;F. Horak;S. Vrtala;S. Spitzauer.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis
Gabrielle Pauli;Tina H. Larsen;Sabina Rak;Friedrich Horak.
The Journal of Allergy and Clinical Immunology (2008)
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski.
Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
G. Pittner;S. Vrtala;W. R. Thomas;M. Weghofer.
Clinical & Experimental Allergy (2004)
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
Alain Didier;Margitta Worm;Friedrich Horak;Gordon Sussman.
The Journal of Allergy and Clinical Immunology (2011)
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity
Jürgen Reisinger;Friedrich Horak;Gabrielle Pauli;Marianne van Hage.
The Journal of Allergy and Clinical Immunology (2005)
Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
Friedrich Horak;Petra Zieglmayer;René Zieglmayer;Patrick Lemell.
The Journal of Allergy and Clinical Immunology (2009)
Systemic Immunological Changes Induced by Administration of Grass Pollen Allergens via the Oral Mucosa during Sublingual Immunotherapy
C. Fanta;B. Bohle;W. Hirt;U. Siemann.
International Archives of Allergy and Immunology (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: